New drug trial targets dangerous sugar crashes after gastric bypass
NCT ID NCT05721729
Summary
This study tested whether a medication called mizagliflozin could help control severe low blood sugar episodes that sometimes occur after weight-loss surgery. Fifteen people who had undergone gastric bypass and experienced these episodes tried the drug and a placebo in different orders. Researchers measured how the drug affected blood sugar levels and safety during the trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTBARIATRIC HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford
Palo Alto, California, 94304, United States
-
University of Colorado / Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.